Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Journal of Visualized Experiments : Jove
|
April 29, 2011
Bimolecular fluorescence complementation
Katy A Wong, John P O'Bryan
Plos One
|
October 3, 2012
A new dimension to Ras function: a novel role for nucleotide-free Ras in Class II phosphatidylinositol 3-kinase beta (PI3KC2β) regulation
Katy A Wong, Angela Russo, Xuerong Wang, et al.
Molecular and Cellular Biology
|
September 19, 2007
Regulation of neuron survival through an intersectin-phosphoinositide 3'-kinase C2beta-AKT pathway
Margaret Das, Erica Scappini, Negin P Martin, et al.
Plos One
|
May 5, 2012
Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks
Katy A Wong, Jessica Wilson, Angela Russo, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 2015
PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations
Helen Y Zou, Qiuhua Li, Lars D Engstrom, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Journal of Visualized Experiments : Jove
|
April 29, 2011
Bimolecular fluorescence complementation
Katy A Wong, John P O'Bryan
Plos One
|
October 3, 2012
A new dimension to Ras function: a novel role for nucleotide-free Ras in Class II phosphatidylinositol 3-kinase beta (PI3KC2β) regulation
Katy A Wong, Angela Russo, Xuerong Wang, et al.
Molecular and Cellular Biology
|
September 19, 2007
Regulation of neuron survival through an intersectin-phosphoinositide 3'-kinase C2beta-AKT pathway
Margaret Das, Erica Scappini, Negin P Martin, et al.
Plos One
|
May 5, 2012
Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks
Katy A Wong, Jessica Wilson, Angela Russo, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 2015
PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations
Helen Y Zou, Qiuhua Li, Lars D Engstrom, et al.
Page
of 1